EVAN SILVERLAND: Open Payments
NPI 1629622584 · WORTHINGTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,330 in 71 payments from 14 companies in 2025. Trend: 2023 $916 · 2024 $1,130 · 2025 $1,330
Food & beverage: $1,330
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $341 |
| Otsuka America Pharmaceutical, Inc. | 9 | $246 |
| Vanda Pharmaceuticals Inc. | 10 | $196 |
| Supernus Pharmaceuticals, Inc. | 7 | $135 |
| Neurocrine BioSciences, Inc. | 3 | $83 |
| Lundbeck LLC | 3 | $67 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Bausch Health US, LLC | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
Products named: VRAYLAR, REXULTI, Qelbree, HETLIOZ, FANAPT, INGREZZA, Jornay PM, APLENZIN.
Industry payments across OH — which companies pay providers there.
